Gene Predictis - Crunchbase Company Profile & Funding

Q: Where is Gene Predictis's headquarters?

Gene Predictis is located in Lausanne, Vaud, Switzerland.

Q: When was the last funding round for Gene Predictis?

Gene Predictis closed its last funding round on obfuscated from a Seed round.

Q: How much funding has Gene Predictis raised to date?

Gene Predictis has raised obfuscated.

Overview

Gene Predictis

Total Funding

obfuscation

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Gene Predictis

CB Rank

3039323

Gene Predictis is a Swiss precision medicine company.

Acquired by

NIMGenetics

Founded

obfuscation

Private

Seed

Lausanne, Vaud, Switzerland

1-10

www.genepredictis.com/

Biotechnology

Genetics

Health Care

Medical

Precision Medicine

Funding Rounds

Seed

OBF

obfuscation

Key People

Joëlle Michaud: Chief Scientific Officer
Alain Mottaz: Co-Founder

Details

Legal Name

Gene Predictis SA

Operating Status

Active

Company Type

For Profit

Founders

Alain Mottaz

About the Company

Gene Predictis is a Swiss company dedicated to personalized medicine. Their main objective is the development of innovative diagnostic tools based on genetics that allow tailored treatments for patients. Their products enable to improve drug treatment efficacy and/or significantly reduce harmful side effects resulting from adverse drug

reactions.

Phone Number

+41216914375

Contact Email

info@genepredictis.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Cypass®

A genetic test assessing the overall risk of adverse drug reactions by analyzing patient drug metabolism and interactions.

Extended Cypass®

An expanded version of Cypass® that evaluates a broader range of genetic factors influencing drug response and adverse effects.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Gene Predictis	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Gene Predictis	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Gene Predictis	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Gene Predictis	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Gene Predictis	—	obfuscated obfuscation	—	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Gene Predictis	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Gene Predictis	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Gene Predictis	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Gene Predictis	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Gene Predictis	—	obfuscated obfuscation	—	Seed